These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19087359)

  • 1. Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.
    Dumitrascu R; Koebrich S; Dony E; Weissmann N; Savai R; Pullamsetti SS; Ghofrani HA; Samidurai A; Traupe H; Seeger W; Grimminger F; Schermuly RT
    BMC Pulm Med; 2008 Dec; 8():25. PubMed ID: 19087359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocrotaline pyrrole induces pulmonary endothelial damage through binding to and release from erythrocytes in lung during venous blood reoxygenation.
    Xiao R; Zhu L; Su Y; Zhang J; Lu Y; Li J; Wang T; Fang J; Jing ZC; Dupuis J; Luo S; Hu Q
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L798-L809. PubMed ID: 30785344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
    Schultze AE; Emeis JJ; Roth RA
    Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension.
    Kodavanti UP; Jackson MC; Ledbetter AD; Richards JR; Gardner SY; Watkinson WP; Campen MJ; Costa DL
    J Toxicol Environ Health A; 1999 Aug; 57(8):543-63. PubMed ID: 10515573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
    Sun XQ; Klouda T; Barnasconi S; Schalij I; Schwab J; Nielsen-Kudsk AH; Axelsen JS; Andersen A; Aman J; de Man FS; Bogaard HJ; Yuan K; Yoshida K
    Am J Physiol Lung Cell Mol Physiol; 2024 Aug; 327(2):L250-L257. PubMed ID: 38810241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monocrotaline induce pulmonary hypertension in animal models].
    Alexandru B; Bogdan MA
    Pneumologia; 2001; 50(2):85-9. PubMed ID: 11584679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.
    Schultze AE; Roth RA
    J Toxicol Environ Health B Crit Rev; 1998; 1(4):271-346. PubMed ID: 9776954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension.
    Chen EP; Bittner HB; Tull F; Craig D; Davis RD; Van Trigt P
    J Thorac Cardiovasc Surg; 1997 May; 113(5):849-57. PubMed ID: 9159618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1989 Jun; 99(2):302-13. PubMed ID: 2734793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Bruner LH; Bull RW; Roth RA
    Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The monocrotaline model of pulmonary hypertension in perspective.
    Gomez-Arroyo JG; Farkas L; Alhussaini AA; Farkas D; Kraskauskas D; Voelkel NF; Bogaard HJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(4):L363-9. PubMed ID: 21964406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
    Lappin PB; Roth RA
    Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension.
    Fujita N; Yamasaki N; Eto K; Asaeda M; Kuwahara W; Imagita H
    PLoS One; 2018; 13(9):e0204254. PubMed ID: 30235299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
    Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC; Wilson DW; Segall HJ
    Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.
    Lachant DJ; Meoli DF; Haight D; Lyons JA; Swarthout RF; White RJ
    Exp Lung Res; 2018 Feb; 44(1):51-61. PubMed ID: 29381088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early progression of pulmonary hypertension in the monocrotaline model in males is associated with increased lung permeability.
    Rafikova O; James J; Eccles CA; Kurdyukov S; Niihori M; Varghese MV; Rafikov R
    Biol Sex Differ; 2020 Mar; 11(1):11. PubMed ID: 32188512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.
    Raoul W; Wagner-Ballon O; Saber G; Hulin A; Marcos E; Giraudier S; Vainchenker W; Adnot S; Eddahibi S; Maitre B
    Respir Res; 2007 Jan; 8(1):8. PubMed ID: 17263874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.